Tag Archives: Mice Model Market

Mice Model Market: Expected Advancements & Global Industry Analysis 2023

In order to ensure high product differentiation, the leading players in the global mice model market are focusing on extensive research and development. Transparency Market Research (TMR) observes that the rising trend of outsourcing mice models to pharmaceutical companies and contract research organizations (CRO) in emerging markets has increased competition as well as market growth. The leading players in the global market are Charles River, The Jackson Laboratory, Harlan Laboratories, and Taconic Biosciences Inc.

The global mice model market was valued at US$1.06 bn in 2015 and is expected to reach US$1.74 bn by 2023, rising at a CAGR of 6.4% between 2015 and 2023. By specialty, the metabolism and regulation segment dominated the market in terms of revenue in 2015. However, oncology will surpass this segment by 2016. The increasing incidence of cancer and the high overall cost of cancer are constantly pushing companies to develop more efficient therapeutics. This, in turn, has increased the demand for mice models in the field of oncology. The diabetes segment is expected to exhibit a noteworthy CAGR of 10.4% during the forecast period owing to the rising prevalence of diabetes.

This 155 page report gives readers a comprehensive overview of the mice model market. Browse through 20 data tables and 79 figures to unlock the hidden opportunities in this market: http://www.transparencymarketresearch.com/mice-model-market.html

Presence of Large Number of Research Institutions to Put North America at Forefront

North America will continue to remain the leading geographical segment until 2023, reaching a valuation of US$785.4 mn that year. The presence of a large number of biopharmaceutical companies and research institutions has been instrumental in driving the growth of the region. Asia Pacific is likely to expand at a CAGR of 11.1% during the same period. Factors such as rising healthcare expenditure, improving research infrastructure, and conducive regulatory environment are contributing to the growth of the Asia Pacific mice model market.

Launch of Advanced Mice Models to Stimulate Market Growth

In the past few years, the market has experienced an influx of several mice models. “The development of advanced mice models is not only boosting the application, but also the applicability of these models for complex diseases,” says TMR’s lead analyst. For instance, in 2015, the ALS Association-funded project created a mouse model of the disease using the mutant C9orf72 gene. The model is expected to be highly valuable in studying the disease process and testing therapies against this form of the disease. The development of such models is augmenting market as well as attracting funds for biomedical research. Moreover, the introduction of personalized in vivo analysis mice models, fueled by the need for fast and accurate treatment, is bolstering the growth of the global market.

Rising Concerns Regarding Animal Use to Take its Toll on Mice Model Market

Globally, the increasing concerns regarding the usage of animals for research and teaching purposes are restraining the growth of the mice model market. Several international social organizations such as PETA believe that the use of animals is morally unacceptable and it should be banned. TMR predicts that the agitation against animal use would grow further in the future, which might slow down the growth of the animal research industry.

Request a sample of this report to know what opportunities will emerge in the rapidly evolving mice model market during 2015 – 2023: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2085

With so many sophisticated non-animal product tests now available, companies are looking for alternative tools that are faster and more cost-effective than animal tests. Although these technologies are still in development phases, these would hamper the growth of the animal research industry.

The information presented in this review is based on a Transparency Market Research report, titled,“Mice Model Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015–2023.”

 

Mice Model Market – Current status and future trends

Global Mice Model Market: Snapshot

Biomedical research has taken a front seat in the healthcare and pharmaceutical industries, to a point where a nation’s research and development landscape can be gauged by its level of investment in biomedical research. The past decade has consequently witnessed a staggering rise in biomedical research in most countries, both developed and developing. A significant part of this research investment typically goes into animal models, more specifically, mice models. This forms the primary driver for the global mice models market.

Another factor promoting the increased use of mice models is the recent number of improvements that have been made in mice models. These improvements have not only enhanced their utility in current applications, but also increased the overall scope of applications for mice models. Biomedical research can use mice models for increasingly complex diseases, such as the use of mutated mice models for studying the ALS disease, or the use of advanced mice models to understand lung injury repair.

This 155 page report gives readers a comprehensive overview of the mice model market. Browse through 20 data tables and 79 figures to unlock the hidden opportunities in this market: http://www.transparencymarketresearch.com/mice-model-market.html

The factors above and similar ones that promote the use of mice models are responsible for imparting a positive growth rate to the global mice models market, which is expected to be valued at US$1.79 bn by the end of 2023.

Demand for Mice Models in North America Remains High

44.9% of the global market for mice models is expected to be held by North America in 2023, in terms of revenue. Europe at the same time is expected to emerge as the second-leading market for mice models, followed closely by Asia Pacific. North America and Europe have an established pharmaceutical industry and an advanced biosciences research field. Both regions are still showing a high demand for mice models that are meant to be used in advanced drug discovery processes and other medical research.

However, their overall share in the market value has dropped since 2014, owing to the significantly high demand for mice models in Asia Pacific. This region is showing an especially high demand for knockout and transgenic mice models. Close to half of the global mice models business in the world for these types is taken up by the Asia Pacific countries of China, India, Malaysia, and Singapore.

Inbred Mice Models Continue to Show High Demand, Demand for Hybrid Models on the Rise

Request a sample of this report to know what opportunities will emerge in the rapidly evolving mice model market during 2015 – 2023: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2085

Based on model types, the global market for mice models is expected to progress at a CAGR of 6.4% from 2015 to 2023, ending at US$1.79 bn by the end of 2023. Among the various mice model types, inbred mice models have consistently been the popular ones, owing to the ease with which scientists can reproduce the data and the overall cost effective system of obtaining inbred mice models. Additionally, the size of samples in inbred mice models can be considerably smaller than their outbred counterparts.

However, the demand for congenic or hybrid mice models is expected to rise significantly over the coming years owing to a high preference for them in the expanding cardiovascular research. Transgenic mice models are the second most popular models in the world. They possess a high volume of research capability in the fields of angiogenesis, breast cancer, and Alzheimer’s disease.

The key providers of mice models from a global standpoint include Charles River Laboratories, The Jackson Laboratory, Harlan Laboratories, and Taconic Biosciences.

 

Mice Model Market: Expected Advancements & Global Industry Analysis 2023

Global Mice Model Market: Snapshot

Biomedical research has taken a front seat in the healthcare and pharmaceutical industries, to a point where a nation’s research and development landscape can be gauged by its level of investment in biomedical research. The past decade has consequently witnessed a staggering rise in biomedical research in most countries, both developed and developing. A significant part of this research investment typically goes into animal models, more specifically, mice models. This forms the primary driver for the global mice models market.

Another factor promoting the increased use of mice models is the recent number of improvements that have been made in mice models. These improvements have not only enhanced their utility in current applications, but also increased the overall scope of applications for mice models. Biomedical research can use mice models for increasingly complex diseases, such as the use of mutated mice models for studying the ALS disease, or the use of advanced mice models to understand lung injury repair.

This 155 page report gives readers a comprehensive overview of the mice model market. Browse through 20 data tables and 79 figures to unlock the hidden opportunities in this market: http://www.transparencymarketresearch.com/mice-model-market.html

The factors above and similar ones that promote the use of mice models are responsible for imparting a positive growth rate to the global mice models market, which is expected to be valued at US$1.79 bn by the end of 2023.

Demand for Mice Models in North America Remains High

44.9% of the global market for mice models is expected to be held by North America in 2023, in terms of revenue. Europe at the same time is expected to emerge as the second-leading market for mice models, followed closely by Asia Pacific. North America and Europe have an established pharmaceutical industry and an advanced biosciences research field. Both regions are still showing a high demand for mice models that are meant to be used in advanced drug discovery processes and other medical research.

However, their overall share in the market value has dropped since 2014, owing to the significantly high demand for mice models in Asia Pacific. This region is showing an especially high demand for knockout and transgenic mice models. Close to half of the global mice models business in the world for these types is taken up by the Asia Pacific countries of China, India, Malaysia, and Singapore.

Inbred Mice Models Continue to Show High Demand, Demand for Hybrid Models on the Rise

Request a sample of this report to know what opportunities will emerge in the rapidly evolving mice model market during 2015 – 2023: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2085

Based on model types, the global market for mice models is expected to progress at a CAGR of 6.4% from 2015 to 2023, ending at US$1.79 bn by the end of 2023. Among the various mice model types, inbred mice models have consistently been the popular ones, owing to the ease with which scientists can reproduce the data and the overall cost effective system of obtaining inbred mice models. Additionally, the size of samples in inbred mice models can be considerably smaller than their outbred counterparts.

However, the demand for congenic or hybrid mice models is expected to rise significantly over the coming years owing to a high preference for them in the expanding cardiovascular research. Transgenic mice models are the second most popular models in the world. They possess a high volume of research capability in the fields of angiogenesis, breast cancer, and Alzheimer’s disease.

The key providers of mice models from a global standpoint include Charles River Laboratories, The Jackson Laboratory, Harlan Laboratories, and Taconic Biosciences.

 

Mice Model Market Current Scenario Analysis with Forecast by 2023

The extremely consolidated global market for mice models is primarily dominated by the players Charles River, The Jackson Laboratory, and Harlan Laboratories – three companies that collectively occupied 75% of the market in 2014 in terms of value.

At the time, the market was predominantly controlled by a small number of players, mostly owing to the disparity in demand between developed and developing economies. However, as the rate of development of emerging economies and their biomedical industries ramps up, so does their demand for mice models.

The resultant effect on the competitive landscape for the global mice models market is a significant growth in the number of regional players in the emerging economies. They pose a direct threat to the globally prominent players that are trying to invest in the opportunities that these regions hold.

According to a new publication by Transparency Market Research, the trend of outsourcing mice models to CROs and pharma companies is also driving the global demand for mice models.

This 155 page report gives readers a comprehensive overview of the mice model market. Browse through 20 data tables and 79 figures to unlock the hidden opportunities in this market: http://www.transparencymarketresearch.com/mice-model-market.html

There is, however, considerable strain on the market’s growth rate due to the stringent regulations applied by global healthcare and pharmaceutical bodies.

Advancements in Mice Model Types and Services Add to Research Scope and Capabilities

“The ALS Association had recently shown the use of mutated mice models for the study of the disease,” states a TMR analyst. “This is only one of the many examples that can show that the recent advancements in mice model types and services have not only added to the strength of existing research processes, but have also expanded the scope of mice model use within other medical research fields.”

New mice models are found to be acceptable in the studies of advanced diseases, a fact which is greatly driving the demand for mice models. They can now be used in advanced research such as lung disease repair.

The integral nature of the mice models market with the pharmaceutical and biomedical fields has allowed companies from these industries to form alliances that can even revolve around further advancing the mice models types and services in the future.

Growing Scope of Alternative Technologies Restrains Use of Mice Models

A lot of companies are currently seeking non-animal test methods for their research processes in order to either eliminate animal use completely or to restrict it as much as possible. Alternatives include solutions such as the Irritation Assay System which is a simplified procedure in a test tube used for skin irritation, or even human skin culture.

A lot of these alternatives are not only cheaper but also provide a faster and more accurate conclusion formation process. This complements the reduction in use of animal models due to the growing protests by people against their use.

In another alternative, professionals are adopting computer-generated simulations to test their processes, further reducing the need for animal models.

North America Retains Leading Demand for Mice Models While APAC Demand Soars

The global market for mice models is expected to be evaluated at US$1.79 bn by the end of 2023

Request a sample of this report to know what opportunities will emerge in the rapidly evolving mice model market during 2015 – 2023: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2085

North America has consistently been a key region in terms of demand for mice models. By the end of 2023, this region is expected to generate a revenue of US$785.4 mn. Meanwhile, the demand for mice models is expected to expand at a CAGR of 11.1% in Asia Pacific, from 2015 to 2023.

An immense demand for genetically engineered mice models is expected to put this service type in the leading position by 2023, with an expected revenue of US$155.2 mn. Mouse breeding and re-derivation have so far been the more popular mice model service types but are likely to be replaced by genetically engineered models soon.

Inbred mice models have consistently been the more popular mice model types. By the end of 2023, the revenue earned by the inbred mice model segment is expected to reach US$340.6 mn.

The information presented in this review is based on a Transparency Market Research report, titled, “Mice Model Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 – 2023.”

 Key Takeaways:

  • By 2023, inbred mice models are expected to generate a revenue of US$340.6 mn.
  • Genetically engineered mice is expected to be the leading service by 2023. By 2023, its revenue is expected to reach US$155.2 mn.
  • North America is expected to continue leading the consumption amount and rate till 2023. By 2023, North America will generated a revenue of US$785.4 mn in mice models.

 

Mice Model Market Current Scenario Analysis with Forecast by 2023

In the last couple of decades, mouse modelling has emerged as a premier mammalian model system for conducting effective genetic research. Mice models have long remained the basis of fundamental and applied research in life science, and are continuing to exhibit robust growth. Due to the close psychological and genetic similarities between mice and humans, scientists hailing from diverse biomedical fields have gravitated to mice models. Furthermore, the ease with which the genomes of mice can be manipulated and analyzed has also given a boost to the global mice model market.

In its latest report, Transparency Market Research has pegged the overall value of the global mice model at US$1 bn in 2014. The market is projected to reach US$1.7 bn by the end of 2023. If the figures hold true, the global mice model market will exhibit a 6.4% CAGR between 2015 and 2023. Although worms, yeasts, and flies are considered excellent models for scrutinizing the cell cycle and development process, mice have proven to be a far better tool for studying the nervous, skeletal, cardiovascular, endocrine, immune, and other complex physiological systems that mammals share.

View exclusive Global strategic Business Report : http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2085

Genetic Similarities of Mice with Other Mammals Boost Market for Mice Model

Like humans and several other mammals, mice often develop diseases that negatively affecttheir immune systems such as cancer, diabetes, oestoporasis, hypertension, glaucoma, and others. Furthermore, certain diseases that affect humans but do not naturally occur in mice, such as Alzheimer’s and cystic fibrosis, can be induced in mice by manipulating their genome to study the effect of novel therapeutics in the treatment of such ailments. The demand for mice model, therefore, increases with the rising funding in research and development to find possible cures for chronic ailments.

Mice present low cost of maintenance and have the ability to multiply rapidly, reproducing as often as nine weeks. This further adds to their appeal as models for biomedical research.

Development of New Therapeutics with Mice Models Propels Mice Model Market

Development of mice models for studying the effects of potential therapeutics in the treatment of certain specific diseases and debilitating health conditions has accelerated tremendously in the last couple of years. The development has been so rapid that mice models have become indispensable in the evaluation of both pipeline and established treatment modalities, particularly in cases of cardiovascular diseases, cancer, neurological disorders, and metabolic anomalies.

Application of mice models in drug discovery enables the development of novel therapeutics strategies, target identification and validation, disease treatment, drug screening, and toxicity and safety screening.

Ethical Issues and Stringent Regulations Hinder Global Mice Model Market

The latest advances in genetic engineering that assist in evaluating a drug’s mechanism of action will boost the market for drug discovery. This in turn is likely to fuel demand from the mice model market. However, on the flip side, stringent regulatory frameworks precisely controlling the use of animals for research in laboratories, rising concerns pertaining to animal cruelty, and other ethical concerns related to the use of animals will have an adverse impact on the overall mice model market.